PMS FLUPHENAZINE TAB 2MG DIN 00726346
Health Canada record
| Active ingredient(s) | FLUPHENAZINE HYDROCHLORIDE 2 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AB02 FLUPHENAZINE |
| Original market date | 31-Dec-1992 |
| Current status date | 04-Jul-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUPHENAZINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00405345 | FLUPHENAZINE | AA PHARMA INC | Tablet | FLUPHENAZINE HYDROCHLORIDE 1 MG | Marketed |
| 00405361 | FLUPHENAZINE | AA PHARMA INC | Tablet | FLUPHENAZINE HYDROCHLORIDE 5 MG | Marketed |
| 00410632 | FLUPHENAZINE | AA PHARMA INC | Tablet | FLUPHENAZINE HYDROCHLORIDE 2 MG | Marketed |
| 00405353 | APO FLUPHENAZINE TAB 2.5MG | APOTEX INC | Tablet | FLUPHENAZINE HYDROCHLORIDE 2.5 MG | Cancelled Post Market |
| 00563846 | FLUPHENAZINE 1 TAB 1MG | PRO DOC LIMITEE | Tablet | FLUPHENAZINE HYDROCHLORIDE 1 MG | Cancelled Post Market |
| 00563838 | FLUPHENAZINE 2 TAB 2MG | PRO DOC LIMITEE | Tablet | FLUPHENAZINE HYDROCHLORIDE 2 MG | Cancelled Post Market |
| 00563803 | FLUPHENAZINE 5 TAB 5MG | PRO DOC LIMITEE | Tablet | FLUPHENAZINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 00582514 | MODITEN HCL TAB 10MG | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Tablet | FLUPHENAZINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00726338 | PMS FLUPHENAZINE TAB 1MG | PHARMASCIENCE INC | Tablet | FLUPHENAZINE HYDROCHLORIDE 1 MG | Cancelled Post Market |
| 00726354 | PMS FLUPHENAZINE TAB 5MG | PHARMASCIENCE INC | Tablet | FLUPHENAZINE HYDROCHLORIDE 5 MG | Cancelled Post Market |
International API supply for FLUPHENAZINE HYDROCHLORIDE
8 active FDA Drug Master Files.
Request a quote for PMS FLUPHENAZINE TAB 2MG